Tetra Bio-Pharma Inc. (TBPMF) Goes After the Cannabis Oil Medical Market

Tetra Bio-Pharma Goes After the Cannabis Oil Medical Market and Launches a Phase 4 Trial with Cannabis Oils in Partnership with Santé Cannabis Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX VENTURE:TBP)(TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced the launch of a medical cannabis oil program as it targets penetrating
Complete Reading

Alternate Health Invited to Present at the American Medical Marijuana Physicians Association’s Annual Conference   TORONTO, Oct. 5, 2017 – Alternate Health Corp (“Alternate Health” or the “Company”) (CSE:AHG) (OTC:AHGIF), an international medical cannabis company that uses best-in-class technology, research, education, production and laboratories to increase the awareness, regulatory compliance, and appropriate usage of cannabinoids
Complete Reading

Presbia continues rally, up 18% ahead of European medical conference Presbia continues rally Thinly-traded nano cap Presbia PLC (LENS +18.1%) continues northward on triple normal volume, albeit on turnover of only 40K shares. The stock has almost doubled in a month. Presbia continues rally Next week, the company will participate in the European Society of Cataract and Refractive
Complete Reading

American Medical Marijuana Physicians Association Endorses Alternate Health’s CanaPass Patient Management System   Toronto, ON, September 25, 2017 – Alternate Health Corp (“Alternate Health” or the “Company”) (CSE:AHG) (OTC:AHGIF), an international medical cannabis company that uses best-in-class technology, research, education, production and laboratories to increase the awareness, regulatory compliance, and appropriate usage of cannabinoids in
Complete Reading

Medical Marijuana: Canopy Growth In Australia Ontario, Canada-based Canopy Growth Corp. said it has signed a supply agreement with AusCann Group Holdings Ltd. to be its exclusive supplier of medical cannabis for the Australian market. Canopy will transfer a range of medicines for research and commercialization in Australia. The deal will also allow Canopy to
Complete Reading

Create Account



Log In Your Account